-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Medline, Maintains $55 Price Target

Benzinga·08/27/2026 11:44:38
Listen to the news
BTIG analyst David Larsen reiterates Medline (NASDAQ:MDLN) with a Buy and maintains $55 price target.